Deepak M.W. Balak

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker et al. · Allergy · 2019 · 149 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +15

In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine

Meng Xu, Jingwen Deng, Kaikun Xu et al. · Theranostics · 2019 · 129 citations · Full text

Life Sciences, Biochemistry, Dermatology +16

IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis

Deepak M.W. Balak, Martijn B. A. van Doorn, Robert D. Arbeit et al. · Clinical Immunology · 2016 · 96 citations

Medicine, Immunology, Pharmacology +15

Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis

Emmerik F A Leijten, Tessa S. van Kempen, Michel A. Olde Nordkamp et al. · Arthritis & Rheumatology · 2021 · 87 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis

Roselie Achten, Daphne S. Bakker, Lieneke F.M. Ariëns et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 55 citations · Full text

Life Sciences, Dermatology, Immunology +16